SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 191 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $124,000 | -16.8% | 16,551 | +0.0% | 0.00% | 0.0% |
Q3 2021 | $149,000 | -24.7% | 16,546 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $198,000 | -4.3% | 16,546 | -0.1% | 0.00% | 0.0% |
Q1 2021 | $207,000 | -28.4% | 16,556 | -10.6% | 0.00% | -50.0% |
Q4 2020 | $289,000 | -19.0% | 18,516 | -50.9% | 0.00% | 0.0% |
Q3 2020 | $357,000 | -16.6% | 37,749 | -20.9% | 0.00% | -33.3% |
Q2 2020 | $428,000 | -24.1% | 47,746 | -46.0% | 0.00% | -40.0% |
Q1 2020 | $564,000 | -23.8% | 88,476 | +0.1% | 0.01% | 0.0% |
Q4 2019 | $740,000 | +10.6% | 88,376 | +19.5% | 0.01% | 0.0% |
Q3 2019 | $669,000 | -16.1% | 73,944 | -0.1% | 0.01% | 0.0% |
Q2 2019 | $797,000 | +150.6% | 74,044 | +122.3% | 0.01% | +150.0% |
Q1 2019 | $318,000 | -16.8% | 33,314 | 0.0% | 0.00% | -33.3% |
Q4 2018 | $382,000 | -30.3% | 33,314 | +3.1% | 0.00% | -25.0% |
Q3 2018 | $548,000 | +19.4% | 32,314 | 0.0% | 0.00% | +33.3% |
Q2 2018 | $459,000 | -25.2% | 32,314 | 0.0% | 0.00% | -40.0% |
Q1 2018 | $614,000 | +15.8% | 32,314 | 0.0% | 0.01% | +25.0% |
Q4 2017 | $530,000 | +9.7% | 32,314 | +0.3% | 0.00% | 0.0% |
Q3 2017 | $483,000 | +70.7% | 32,214 | 0.0% | 0.00% | +33.3% |
Q2 2017 | $283,000 | +68.5% | 32,214 | 0.0% | 0.00% | +50.0% |
Q1 2017 | $168,000 | +71.4% | 32,214 | 0.0% | 0.00% | +100.0% |
Q4 2016 | $98,000 | -34.2% | 32,214 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $149,000 | -22.8% | 32,214 | 0.0% | 0.00% | -50.0% |
Q2 2016 | $193,000 | -1.0% | 32,214 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $195,000 | -33.7% | 32,214 | 0.0% | 0.00% | -33.3% |
Q4 2015 | $294,000 | +61.5% | 32,214 | 0.0% | 0.00% | +50.0% |
Q3 2015 | $182,000 | -49.0% | 32,214 | 0.0% | 0.00% | -50.0% |
Q2 2015 | $357,000 | -10.3% | 32,214 | 0.0% | 0.00% | -20.0% |
Q1 2015 | $398,000 | -34.3% | 32,214 | -19.2% | 0.01% | 0.0% |
Q4 2014 | $606,000 | +181.9% | 39,888 | +100.0% | 0.01% | +25.0% |
Q3 2014 | $215,000 | -29.5% | 19,944 | 0.0% | 0.00% | -33.3% |
Q2 2014 | $305,000 | -15.5% | 19,944 | 0.0% | 0.01% | -25.0% |
Q1 2014 | $361,000 | +30.3% | 19,944 | 0.0% | 0.01% | -11.1% |
Q4 2013 | $277,000 | +32.5% | 19,944 | 0.0% | 0.01% | +28.6% |
Q3 2013 | $209,000 | +34.0% | 19,944 | 0.0% | 0.01% | +75.0% |
Q2 2013 | $156,000 | – | 19,944 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |